• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

142
20
13
13
11

COUNTRY

6
4
4
4
3

PRICE

86
91
123
517

PUBLISHED

1
14
137
517

PRODUCT TYPE

511
3
2
1

Immune Disorders

(517 Products)

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

Cat Allergy - Pipeline Review, H1 2015

Cat Allergy - Pipeline Review, H1 2015 Summary This, ‘Cat Allergy - Pipeline Review, H1 2015’, provides an overview of the Cat Allergy’s therapeutic pipeline. This report provides comprehensive information...

February 2015
FROM

Analysis of Barclays plc

Barclays Plc is a major global financial services company based in London. In 2010, the company was measured as being the tenth largest banking and financials services company in the world by Forbes....

February 2015
FROM

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015 Summary This, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s...

January 2015
FROM

Ragweed Allergy - Pipeline Review, H1 2015

Ragweed Allergy - Pipeline Review, H1 2015 Summary This, ‘Ragweed Allergy - Pipeline Review, H1 2015’, provides an overview of the Ragweed Allergy’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

House Dust Mite Allergy - Pipeline Review, H1 2015

House Dust Mite Allergy - Pipeline Review, H1 2015 Summary This, ‘House Dust Mite Allergy - Pipeline Review, H1 2015’, provides an overview of the House Dust Mite Allergy’s therapeutic pipeline. This...

January 2015
FROM

Birch Pollen Allergy - Pipeline Review, H1 2015

Birch Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Birch Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Birch Pollen Allergy’s therapeutic pipeline. This report...

January 2015
FROM

Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015 Summary This, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

January 2015
FROM

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

Chronic Plaque Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline. This...

January 2015
FROM

Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the...

December 2014
FROM

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity...

December 2014
FROM

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

December 2014
FROM

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the...

December 2014
FROM

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints....

December 2014
FROM

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

December 2014
FROM

RAVAX (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

RAVAX (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects...

December 2014
FROM

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints...

December 2014
FROM

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints....

December 2014
FROM
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare